Search This Blog

Thursday, October 31, 2019

Agios Pharmaceuticals EPS misses by $0.02, misses on revenue

Agios Pharmaceuticals (NASDAQ:AGIO): Q3 GAAP EPS of -$1.81 misses by $0.02.
Revenue of $26M (+196.8% Y/Y) misses by $7.13M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)